Enosi Life Sciences Featured on America’s Next Investment
25 mai 2021 08h00 HE
|
Enosi Life Sciences
EUGENE, Ore., May 25, 2021 (GLOBE NEWSWIRE) -- Enosi Life Sciences Corp. (“Enosi” or the “Company”), a drug research and development company focused on providing industry-leading therapeutics for...
Enosi Life Sciences Announces Executive Appointments as the Company Prepares for Period of Growth
29 avr. 2021 07h30 HE
|
Enosi Life Sciences
SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) -- Enosi Life Sciences, a drug research and development company focused on providing industry-leading therapeutics for inflammatory autoimmune diseases and...
Enosi Life Sciences Appoints Drug Discovery Veteran Patrick Gray as its Newest Board Member
16 févr. 2021 09h00 HE
|
Enosi Life Sciences
SAN DIEGO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Enosi Life Sciences, a drug research and development company focused on providing industry-leading therapeutics for inflammatory autoimmune diseases and...
Enosi Life Sciences Files Patent for TNF-Inhibiting Molecules EN1001, EN2001 and EN3001
18 nov. 2020 09h00 HE
|
Enosi Life Sciences
SAN DIEGO, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Enosi Life Sciences Corp. (“Enosi” or the “Company”), a drug research and development company focused on providing industry-leading therapeutics for...
Enosi Life Sciences Launches Regulation D Offering to Fund Antibody Therapeutics Development
29 sept. 2020 09h00 HE
|
Enosi Life Sciences
SAN DIEGO, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Enosi Life Sciences Corp. (“Enosi” or the “Company”), a drug research and development company focused on providing industry-leading therapeutics for...
Enosi Life Sciences’ Sir Marc Feldmann to Join 2020 Tang Prize Masters’ Forum in Biopharmaceutical Science
21 sept. 2020 09h00 HE
|
Enosi Life Sciences
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Enosi Life Sciences, a drug research and development company focused on providing industry-leading therapeutics for inflammatory autoimmune diseases and...
Enosi Life Sciences Appoints Biotech, Pharma and Venture Capital Veteran Dr. James N. Woody as Executive Chairman
14 sept. 2020 09h00 HE
|
Enosi Life Sciences
Dr. James Woody’s leadership qualities and experience leading innovative pharmaceutical ventures and raising funds will power Enosi’s development of second-generation anti-TNF therapeutics for...
Therapeutic Antibody Pioneers Professor Sir Marc Feldmann and Dr. H. Michael Shepard Formally Launch Enosi Life Sciences
02 sept. 2020 09h00 HE
|
Enosi Life Sciences
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- World-renowned scientists Professor Sir Marc Feldmann and Dr. H. Michael Shepard are pleased to announce the formal launch of Enosi Life Sciences...